NCT01571063View on ClinicalTrials.gov

Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Non-alcoholic Steatohepatitis (NASH)
Interventions
DRUG

Vitamin D3

Vitamin D3, 2.100 IU/d p.o.

DRUG

Placebo

Placebo Tbl. p.o.

Trial Locations (2)

8091

University Hospital Zurich, Gastroenterology and Hepatology, Zurich

Unknown

Kantonsspital St. Gallen, Sankt Gallen

All Listed Sponsors
lead

University of Zurich

OTHER

NCT01571063 - Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D | Biotech Hunter | Biotech Hunter